Credit: CC0 Public Domain A recent study estimates that more than 275,000 people—or 4.6 percent of people over the age of 11 in Massachusetts- have opioid use disorder, a figure nearly four times higher than previous estimates based on national data. Led by researchers at Boston Medical Center, the study involved an analysis of several […]Continue Reading ...
Jan 18 2019 A new study suggests that vital exhaustion – which can be perceived as an indicator of psychological distress – is a risk factor for future risk of dementia. Researchers from the Department of Public Health, University of Copenhagen have, in collaboration with the National Research Centre for the Working Environment, and the […]Continue Reading ...
A group of scientists from Russia’s Ural Federal University, headed by Professor Grigory Zyryanov, synthesized a group of multi-purpose fluorophores. The scientists told about the content and results of their research on the unique technology in a respected international scientific journal Dyes and Pigments. ‘Fluorophores are powders of different colors, which emit visible radiation (in […]Continue Reading ...
Multi-Walled Carbon Nanotubes (MWCNTs) is the name that is derived from their structure and walls are formed by one atom thick sheet of carbon. Using MWCNT as a drug delivery system the requirement for the solvent and drug dissolution in a solution can be avoided. Soyasapogenol B is a derived from soya bean that belongs […]Continue Reading ...
Credit: CC0 Public Domain Tobacco is a known risk factor for the misuse of prescription opioids. In addition, concurrent use of opioids and sedative-hypnotics is a risk factor for opioid overdose or addiction. In an American Journal on Addictions study, tobacco users were more likely to receive prescriptions for opioid analgesics with muscle relaxants and/or […]Continue Reading ...
The World Health Organization (WHO) has created a list of health threats for the New Year. Interestingly, Anti-vaccination movement has featured among the top threats to the world. The anti-vaccination movement comprises of a group of people who are reluctant to getting vaccinated and refuse to vaccinate themselves or their children against vaccine preventable infections. […]Continue Reading ...
Porvair Sciences reports on a highly effective protocol, using its Plant Genomics microplate, for preparing cannabis samples for analysis of Tetrahydrocannabinol (THC) and Cannabidiol (CBD). With increasing legalization of cannabis for medicinal and research purposes, demand for accurate and high throughput analysis of its active ingredients has dramatically risen. Cannabis plant material contains several cannabinoids […]Continue Reading ...
Credit: CC0 Public Domain A Massachusetts General Hospital (MGH)-led research team has demonstrated, for the first time, how solid stress—the physical forces exerted by the solid components of a tumor—impacts the tissue surrounding brain tumors and contributes to resulting neurological dysfunction and neuronal cell death. In their report published in Nature Biomedical Engineering, the investigators […]Continue Reading ...
Jan 18 2019 A new antibiotic developed by a Flinders University researcher is being heralded as a breakthrough in the war against a drug-resistant superbug. Bacteria are winning the fight against antibiotics as they evolve to fight off traditional treatments, threatening decades of advancements in modern medicine, with predictions they will kill over 10 million […]Continue Reading ...
Chronic liver disease is known as the silent killer, as it shows no obvious symptoms until the disease has progressed to an advanced stage. Therefore, making a proper diagnosis in the early stage of disease progression can be a clinical challenge. An international team of researchers, affiliated with UNIST, has identified a novel route that […]Continue Reading ...
Home News New Drugs FDA Approves Ontruzant (trastuzumab-dttb), a Biosimilar to Herceptin January 18, 2019 — FDA today approved Ontruzant (trastuzumab-dttb), a biosimilar to U.S.-licensed Herceptin (trastuzumab). A biosimilar product is a biological product that is approved based on a showing that it is highly similar to an already-FDA approved biological product, known as a […]Continue Reading ...
Jan 16 2019 Men with dyslexia have altered structural connections between the thalamus and auditory cortex on the left side of the brain, new research published in JNeurosci reveals. The study extends similar observations of the dyslexic visual system and highlights the importance of early sensory processing for reading proficiency. Neural fibers connect a subcortical […]Continue Reading ...
A new way of screening babies and adults for future risk of type 1 diabetes will be much more effective at identifying the condition than current methods, new research has concluded. Researchers at the University of Exeter and the Pacific Northwest Research Institute in Seattle have developed a new risk score which takes into account […]Continue Reading ...
January 18, 2019 Audience: Consumer, Health Professional, Pharmacy Prinston Pharmaceutical Inc., dba Solco Healthcare LLC., has initiated a voluntary recall of one (1) lot of Irbesartan and seven (7) lots of Irbesartan HCTZ Tablets to the consumer level due to the detection of trace amount of an unexpected impurity found in an active pharmaceutical ingredient […]Continue Reading ...
Vaccines to stop the world’s next epidemic could be developed in record time under a $14.7 million partnership using technology developed at The University of Queensland. The Coalition for Epidemic Preparedness Innovations (CEPI) has funded a research consortium to develop a rapid response pipeline to develop and test new vaccines in as little as 16 […]Continue Reading ...
- 4.6 percent of Massachusetts residents have opioid use disorder
- New study suggests vital exhaustion as risk factor for dementia
- New antibiotic discovery heralds breakthrough in the fight against drug-resistant bacteria
- Ural Federal University scientists synthesize a group of multi-purpose fluorophores
- Researchers identify new therapeutic target in the fight against chronic liver diseases
- Preparation, characterization of Soyasapogenol B loaded onto functionalized MWCNTs
- FDA Approves Ontruzant (trastuzumab-dttb), a Biosimilar to Herceptin
- Tobacco use linked with higher use of opioids and sedatives
- Study delves deeper into developmental dyslexia
- Anti-vaccination movement one of the top health threats in 2019 says WHO
- Newly developed risk score more effective at identifying type 1 diabetes
- Highly effective protocol to prepare cannabis samples for THC/CBD analysis
- Prinston Pharmaceutical Inc. Issues Voluntary Nationwide Recall of Irbesartan and Irbesartan HCTZ Tablets Due to Detection of a Trace Amount of Unexpected Impurity, N-Nitrosodiethylamine (NDEA) in the Products
- How does solid stress from brain tumors cause neuronal loss, neurologic dysfunction?
- $14.7 million partnership to supercharge vaccine development
- Ian Fotheringham receives Charles Tennant Memorial Lecture award
- Brain vital signs detect neurophysiological impairments in players with concussions
- Lack of job and poor housing conditions increased likelihood of people attending A&E
- Novel targeted drug delivery system improves conventional cancer treatments
- Rutgers study finds gene responsible for spread of prostate cancer